GlaxoSmithKline Inc.
Registration:
31
of
70
(2017-02-13
to
2017-07-27)
Senior Officers whose lobbying activities represent less than 20% of their Duties
-
Paul Lirette,
President and Chief Executive Officer
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
-
Andrew Jones,
Assoc. Director, Federal Affairs
- Date Modified: